StockData

NutriBand vs Pulse Biosciences

NTRB and PLSE side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How NTRB and PLSE compare

Pulse Biosciences is the larger company, worth 47 times as much as NutriBand ($3.2B against $68.0M).

NutriBand keeps more of each dollar of sales as profit, with a net margin of −430% compared with −6756% at Pulse Biosciences.

Pulse Biosciences scores higher on the StockData Score (6 against 4 for NutriBand), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricNTRBPLSE
Size and price
Market cap$68.0M$3.2B
Share price$5.59$44.84
Change, 1 year1.6%211%
Change, 5 years−18.8%107%
Beta (5Y)0.450.50
Employees500116
StockData Score
Total score46 (better)
Valuation score00
Growth score00
Performance score00
Health score46 (better)
Dividend score00
Valuation
P/S42.0× (better)2699×
P/B12.8× (better)32.1×
FCF yield–−1.9%
Fair value$1.72–
Margin of safety−225%–
Growth
Revenue growth (TTM)−37.3%–
Revenue growth, 5Y average16.6%–
Profitability
Gross margin33.1% (better)0.25%
Operating margin−436% (better)−7008%
Net margin−430% (better)−6756%
FCF margin–−5180%
Return on equity−101%−78.5% (better)
Return on invested capital−320%–
Financial health
Debt / equity0.00 (better)0.00
Interest coverage−339.3×–
Current ratio4.219.63 (better)
Altman Z-score28.53111.94 (better)
Piotroski F-score4 (better)3
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions2.9%15.0%
Held by insiders24.5%71.2%
Insider net buying, 12 months–$23.9M
Short interest, % of float1.5%14.1%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.